B. Riley reissued their buy rating on shares of Global Medical REIT, Inc. (NASDAQ:GMRE) in a research note published on Friday morning. B. Riley currently has a $10.50 price objective on the stock. B. Riley also issued estimates for Global Medical REIT’s Q4 2017 earnings at $0.12 EPS, FY2017 earnings at $0.33 EPS, Q1 2018 earnings at $0.15 EPS, Q2 2018 earnings at $0.19 EPS, Q3 2018 earnings at $0.24 EPS, FY2018 earnings at $0.83 EPS, Q1 2019 earnings at $0.25 EPS, Q2 2019 earnings at $0.25 EPS and FY2019 earnings at $1.01 EPS.

Other equities analysts have also issued research reports about the company. FBR & Co reissued a buy rating and set a $10.50 price objective (up previously from $10.00) on shares of Global Medical REIT in a research report on Monday, September 18th. Zacks Investment Research lowered Global Medical REIT from a buy rating to a hold rating in a research report on Tuesday, August 15th. DA Davidson lowered Global Medical REIT from a buy rating to a neutral rating and lowered their price objective for the company from $11.00 to $10.00 in a research report on Tuesday, August 22nd. Finally, Cantor Fitzgerald reissued an overweight rating and set a $12.00 price objective on shares of Global Medical REIT in a research report on Friday, September 1st. One analyst has rated the stock with a sell rating, one has issued a hold rating and five have issued a buy rating to the company. Global Medical REIT presently has a consensus rating of Buy and a consensus target price of $10.60.

Global Medical REIT (NASDAQ GMRE) opened at $9.22 on Friday. Global Medical REIT has a 52-week low of $7.04 and a 52-week high of $10.25.

COPYRIGHT VIOLATION WARNING: This report was originally published by Watch List News and is the property of of Watch List News. If you are viewing this report on another site, it was copied illegally and reposted in violation of United States and international trademark & copyright law. The original version of this report can be viewed at https://www.watchlistnews.com/global-medical-reit-inc-gmre-rating-reiterated-by-b-riley/1702417.html.

Institutional investors and hedge funds have recently bought and sold shares of the company. UBS Group AG raised its position in shares of Global Medical REIT by 14.2% in the 1st quarter. UBS Group AG now owns 11,847 shares of the company’s stock worth $108,000 after purchasing an additional 1,477 shares during the last quarter. SG Americas Securities LLC purchased a new position in shares of Global Medical REIT in the 3rd quarter worth about $115,000. Nomura Asset Management Co. Ltd. purchased a new position in shares of Global Medical REIT in the 3rd quarter worth about $120,000. Spirit of America Management Corp NY raised its position in shares of Global Medical REIT by 50.0% in the 2nd quarter. Spirit of America Management Corp NY now owns 15,000 shares of the company’s stock worth $134,000 after purchasing an additional 5,000 shares during the last quarter. Finally, Wedbush Securities Inc. raised its position in shares of Global Medical REIT by 5.8% in the 2nd quarter. Wedbush Securities Inc. now owns 15,334 shares of the company’s stock worth $137,000 after purchasing an additional 834 shares during the last quarter.

Global Medical REIT Company Profile

Analyst Recommendations for Global Medical REIT (NASDAQ:GMRE)

Receive News & Ratings for Global Medical REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.